Champions Oncology Inc (CSBR)
4.70
-0.03
(-0.63%)
USD |
NASDAQ |
May 17, 16:00
Champions Oncology Shareholders Equity (Quarterly): -2.058M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | -2.058M |
October 31, 2023 | 0.093M |
July 31, 2023 | 1.903M |
April 30, 2023 | 4.636M |
January 31, 2023 | 7.064M |
October 31, 2022 | 9.172M |
July 31, 2022 | 8.983M |
April 30, 2022 | 9.096M |
January 31, 2022 | 9.236M |
October 31, 2021 | 8.071M |
July 31, 2021 | 7.538M |
April 30, 2021 | 7.428M |
January 31, 2021 | 7.867M |
October 31, 2020 | 6.893M |
July 31, 2020 | 5.513M |
April 30, 2020 | 5.099M |
January 31, 2020 | 3.177M |
October 31, 2019 | 2.114M |
July 31, 2019 | 1.728M |
April 30, 2019 | 2.238M |
January 31, 2019 | 2.323M |
October 31, 2018 | 1.992M |
July 31, 2018 | 0.602M |
April 30, 2018 | 0.003M |
January 31, 2018 | 0.472M |
Date | Value |
---|---|
October 31, 2017 | 0.373M |
July 31, 2017 | 0.29M |
April 30, 2017 | 0.40M |
January 31, 2017 | 2.04M |
October 31, 2016 | 3.205M |
July 31, 2016 | 3.176M |
April 30, 2016 | 0.238M |
January 31, 2016 | 2.259M |
October 31, 2015 | 4.102M |
July 31, 2015 | 5.903M |
April 30, 2015 | 8.059M |
January 31, 2015 | -4.144M |
October 31, 2014 | -1.858M |
July 31, 2014 | 0.439M |
April 30, 2014 | 3.197M |
January 31, 2014 | 4.486M |
October 31, 2013 | 4.139M |
July 31, 2013 | 5.987M |
April 30, 2013 | 7.676M |
January 31, 2013 | 9.335M |
October 31, 2012 | -7.184M |
July 31, 2012 | -5.837M |
April 30, 2012 | 2.881M |
January 31, 2012 | -3.38M |
October 31, 2011 | -2.387M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.058M
Minimum
Jan 2024
9.236M
Maximum
Jan 2022
5.450M
Average
6.893M
Median
Oct 2020
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 26.79M |
Total Liabilities (Quarterly) | 28.84M |
Current Ratio | 0.6008 |